A strategy for ZnO nanorod mediated multi-mode cancer treatment

Biomaterials

Volumn 32, Issue 7, 2011, Pages 1906-1914

  Zhang, Haijun ^a   Chen, Baoan ^a   Jiang, Hui ^a   Wang, Cailian ^a   Wang, Huangping ^a   Wang, Xuemei ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Apoptosis; Cancer; Drug delivery system; Photodynamic therapy; ZnO nanorods

Indexed keywords

ANTI-TUMOR ACTIVITIES; ANTI-TUMORS; ANTICANCER DRUG; APOPTOSIS; CANCER; CANCER CELLS; CANCER THERAPY; CANCER TREATMENT; CHEMOTHERAPEUTIC AGENTS; CYTOTOXIC; DAUNORUBICIN; DRUG CARRIER; DRUG DELIVERY SYSTEM; EFFICIENT DRUG DELIVERY; HUMAN HEPATOCARCINOMA; IMMUNOCYTOCHEMISTRY; INTRACELLULAR CONCENTRATION; MTT ASSAYS; MULTIMODES; NEW STRATEGY; PHOTODYNAMIC ACTIVITIES; REACTIVE OXYGEN SPECIES; ROOM TEMPERATURE; SIGNALING PATHWAYS; UV ILLUMINATIONS; ZNO NANOROD;

CARRIER CONCENTRATION; CELL DEATH; DRUG DELIVERY; FLOW CYTOMETRY; NANORODS; ONCOLOGY; OXYGEN; PLASMONS; SOLID STATE REACTIONS; TUMORS; ZINC OXIDE;

PHOTODYNAMIC THERAPY;

CASPASE 3; DAUNORUBICIN; NANOROD; REACTIVE OXYGEN METABOLITE; ZINC OXIDE;

AIR TEMPERATURE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER THERAPY; CELL DAMAGE; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER CELL CARCINOMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; ROOM TEMPERATURE; SOLID STATE; ULTRAVIOLET RADIATION;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; DAUNORUBICIN; DRUG CARRIERS; HUMANS; IMMUNOHISTOCHEMISTRY; MODELS, THEORETICAL; NANOTECHNOLOGY; NANOTUBES; PHOTOCHEMOTHERAPY; REACTIVE OXYGEN SPECIES; ZINC OXIDE;

EID: 78650983813     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.11.027     Document Type: Article

References (22)

1. Bae B.C., Na K. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials 2010, 31:6325-6335.
2. Guo H.C., Qian H.S., Idris N.M., Zhang Y. Singlet oxygen-induced apoptosis of cancer cells using upconversion fluorescent nanoparticles as a carrier of photosensitizer. Nanomed-nanotechnol 2010, 6:486-495.
3. He X.X., Wu X., Wang K.M., Shi B.H., Hai L. Methylene blue-encapsulated phosphonate-terminated silica nanoparticles for simultaneous in vivo imaging and photodynamic therapy. Biomaterials 2009, 30:5601-5609.
4. Khdair A., Gerard B., Handa H., Mao G.Z., Shekhar M.P.V., Panyam J. Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy. Mol Pharmaceut 2008, 5:795-897.
5. Miller J.D., Baron E.D., Scull H., Hsia A., Berlin J.C., McConnick T., et al. Photodynarnic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. Toxicol Appl Pharmacol 2007, 244:290-299.
6. Xu F., Zhang P., Navrotsky A., Yuan Z.Y., Ren T.Z., Halasa M., et al. Hierarchically assembled porous ZnO nanoparticles: synthesis, surface energy, and photocatalytic activity. Chem Mater 2007, 19:5680-5686.
7. Ostrovsky S., Kazimirsky G., Gedanken A., Brodie C. Selective cytotoxic effect of ZnO nanoparticles on glioma cells. Nano Res 2009, 2:882-890.
8. Guo D.D., Wu C.H., Jiang H., Li Q.N., Wang X.M., Chen B.A. Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation. J Photoch Photobio B 2008, 93:119-126.
9. Zhang Y.B., Chen W., Wang S.P., Liu Y.F., Pope C. Phototoxicity of zinc oxide nanoparticle conjugates in human ovarian cancer NIH: OVCAR-3 cells. J Biomed Nanotechnol 2008, 4:432-438.
10. Liu Z., Tabakman S., Welsher K., Dai H.J. Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug deliver. Nano Res 2009, 2:85-120.
11. Wang J.Q., Sui M.H., Fan W.M. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr Drug Metab 2010, 11:129-141.
12. Li Q.N., Wang X.M., Lu X.H., Tian H.E., Jiang H., Lv G., et al. The incorporation of daunorubicin in cancer cells through the use of titanium dioxide whiskers. Biomaterials 2009, 30:4708-4715.
13. Song M., Zhang R.Y., Dai Y.Y., Gao F., Chi H.M., Lv G., et al. The in vitro inhibition of multidrug resistance by combined nanoparticulate titanium dioxide and UV irradiation. Biomaterials 2006, 27:4230-4238.
14. Masquelier M., Zhou Q.F., Gruber A., Vitols S. Relationship between daunorubicin concentration and apoptosis induction in leukemic cells. Biochem Pharmacol 2004, 67:1047-1056.
15. Chen J.Y., Lee Y.M., Zhao D., Mak N.K., Wong R.N.S., Chan W.H., et al. Quantum dot-mediated Photoproduction of reactive oxygen species for cancer cell annihilation. Photochem Photobiol 2010, 86:431-437.
16. Rozhkova E.A., Ulasov I., Lai B., Dimitrijevic N.M., Lesniak M.S., Rajh T. A high-performance nanobio photocatalyst for targeted brain cancer therapy. Nano Lett 2009, 9:3337-3342.
17. Zhou J., Xu N.S., Wang Z.L. Dissolving behavior and stability of ZnO wires in biofluids: a study on biodegradability and biocompatibility of ZnO nanostructures. Adv Mater 2006, 18:2432-2435.
18. Ju-Nam Y., Lead J.R. Manufactured nanoparticles: an overview of their chemistry, interactions and potential environmental implications. Sci Total Environ 2008, 400:396-414.
19. Yoo H.S., Lee K.H., Oh J.E., Park T.G. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Control Release 2000, 68:419-431.
20. Prabaharan M., Grailer J.J., Pilla S., Steeber D.A., Gong S.Q. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. Biomaterials 2009, 30:5757-5766.
21. Petre C.E., Dittmer D.P. Liposomal daunorubicin as treatment for Kaposi's sarcoma. Int J Nanomed 2007, 2:277-288.
22. Ghavami S., Hashemi M., Ande S.R., Yeganeh B., Xiao W., Eshraghi M., et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet 2009, 46:497-510.